Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

EXOSENS Stock: Shares Gain 5.24% Over the Past Week

EXOSENS stock closed on Friday at €58.30, marking a 5.24% increase over the week. This performance significantly outperformed major indices, with the CAC 40 only advancing by 0.19% and the SBF 120 by 0.13% over the same period. Over the year, the stock has risen by 194.4%.


EXOSENS Stock: Shares Gain 5.24% Over the Past Week

Weekly Performance Analysis

EXOSENS stock experienced a dynamic week, closing at €58.30 on Friday, January 16, 2026, up from €57.60 the previous Monday. This positive weekly change of 5.24% follows an upward trajectory, with notable increases on January 12 and 16 (+1.95% and +3.55% respectively), despite intermediate declines on January 13 and 15 (-2.60% and -1.91%). Trading volumes were high, particularly on January 12 with 214,000 shares traded, and 104,000 on January 13, indicating increased capital rotation at the start of the week. Over the past year, the performance reached 194.4%, pushing the price well beyond its January 2025 levels. In comparison, this dynamic contrasts with the modest progress of the CAC 40 (+0.19%) and the SBF 120 (+0.13%) over the week. The stock reached a weekly high of €61.00 on January 12, before stabilizing around €58-59 at the end of the week. This development reflects a monthly volatility of 10.74%, with a beta of 0.13 indicating limited sensitivity to general market movements. The resistance threshold is precisely at €58.30, reached at the close on Friday, while the support is identified at €43.95. Over five days, the cumulative variation is approximately 3.36% according to historical data, confirming the upward trend. The week's highs peaked at €61.00, with lows at €55.20, showing marked intra-day fluctuations but an overall upward orientation. This weekly performance positions EXOSENS among the dynamic stocks, far ahead of benchmark indices.

Mid-Session Market Movements

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

EXOSENS stock was among the strongest risers in the SBF 120 at mid-session on Friday, January 16, 2026. On January 12, it was among the strongest morning movers, alongside Abivax and BESI. These movements occurred in a context of European markets lacking any particular conviction, as noted mid-week. Technically, the stock is significantly above its 50-day moving average, set at €47.61, and its 200-day moving average at €42.42. The MACD indicator shows a line at 3.39, while the RSI is at 83. The upper Bollinger Bands are at €60.88 and the lower at €42.22, thus framing the current price close to the upper boundary.



Sector Défense Défense


Assurance vie

Context

Period
  • Period: 9M 2025
Guidance from the release
  • Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
  • Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
  • Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
  • Dépendance aux budgets de Défense et aux évolutions géopolitiques
  • Risque d'intégration des acquisitions récentes
  • Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
  • Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
  • Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
  • Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
  • Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit